ASTRID LIED: Open Payments
NPI 1548034416 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,508 in 233 payments from 35 companies in 2025. Trend: 2023 $0 · 2024 $1,766 · 2025 $5,508
Food & beverage: $5,490Education: $18
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 62 | $1,097 |
| ABBVIE INC. | 31 | $719 |
| Alexion Pharmaceuticals, Inc. | 12 | $395 |
| TG Therapeutics, Inc. | 4 | $384 |
| ACADIA Pharmaceuticals Inc | 20 | $338 |
| Genentech USA, Inc. | 7 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $261 |
| Biogen, Inc. | 7 | $221 |
| EMD Serono, Inc. | 5 | $187 |
| ARGENX US, INC. | 4 | $182 |
Products named: INGREZZA, QULIPTA, ULTOMIRIS, BRIUMVI, NUPLAZID, UBRELVY, HYQVIA, Ocrevus.
Industry payments across FL — which companies pay providers there.
